Novel antiangiogenic therapy targeting biglycan using tumor endothelial cell‐specific liposomal siRNA delivery system
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel antiangiogenic therapy targeting biglycan using tumor endothelial cell‐specific liposomal siRNA delivery system
Authors
Keywords
-
Journal
CANCER SCIENCE
Volume 113, Issue 5, Pages 1855-1867
Publisher
Wiley
Online
2022-03-10
DOI
10.1111/cas.15323
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Landscape of cancer-associated fibroblasts identifies the secreted biglycan as a protumor and immunosuppressive factor in triple-negative breast cancer
- (2022) Shaoquan Zheng et al. OncoImmunology
- Biglycan, tumor endothelial cell secreting proteoglycan, as possible biomarker for lung cancer
- (2021) Hirofumi Morimoto et al. Thoracic Cancer
- Fibrosis and cancer: A strained relationship
- (2020) Bram Piersma et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Small Leucine Rich Proteoglycans (decorin, biglycan and lumican) in cancer
- (2019) Sandeep Appunni et al. CLINICA CHIMICA ACTA
- Targeting Tumor Endothelial Cells with Nanoparticles
- (2019) Sakurai et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Nucleic acids delivering nucleic acids
- (2018) Silvia Catuogno et al. ADVANCED DRUG DELIVERY REVIEWS
- Biglycan promotes the chemotherapy resistance of colon cancer by activating NF-κB signal transduction
- (2018) Bin Liu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Mapping Hypoxia in Renal Carcinoma with Oxygen-enhanced MRI: Comparison with Intrinsic Susceptibility MRI and Pathology
- (2018) Ross A. Little et al. RADIOLOGY
- Modality of tumor endothelial VEGFR2 silencing-mediated improvement in intratumoral distribution of lipid nanoparticles
- (2017) Shoshiro Yamamoto et al. JOURNAL OF CONTROLLED RELEASE
- Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation
- (2017) Elizabeth Allen et al. Science Translational Medicine
- Altered expression of small leucine-rich proteoglycans (Decorin, Biglycan and Lumican): Plausible diagnostic marker in urothelial carcinoma of bladder
- (2017) Sandeep Appunni et al. TUMOR BIOLOGY
- Biglycan expression in the melanoma microenvironment promotes invasiveness via increased tissue stiffness inducing integrin-β1 expression
- (2017) Hana Andrlová et al. Oncotarget
- Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer
- (2017) Frank Jacobsen et al. NEOPLASIA
- Latest Results for Anti-Angiogenic Drugs in Cancer Treatment
- (2016) Sofie Frandsen et al. CURRENT PHARMACEUTICAL DESIGN
- Tumor angiogenesis—characteristics of tumor endothelial cells
- (2016) Kyoko Hida et al. International Journal of Clinical Oncology
- Biglycan stimulates VEGF expression in endothelial cells by activating the TLR signaling pathway
- (2016) Lei Hu et al. Molecular Oncology
- Remodeling of the Extracellular Matrix by Endothelial Cell-Targeting siRNA Improves the EPR-Based Delivery of 100 nm Particles
- (2016) Yu Sakurai et al. MOLECULAR THERAPY
- Tumour endothelial cells in high metastatic tumours promote metastasis via epigenetic dysregulation of biglycan
- (2016) Nako Maishi et al. Scientific Reports
- CXCL12-CXCR7 axis is important for tumor endothelial cell angiogenic property
- (2015) Kenji Yamada et al. INTERNATIONAL JOURNAL OF CANCER
- Biglycan enhances gastric cancer invasion by activating FAK signaling pathway
- (2015) Lei Hu et al. Oncotarget
- Identification of novel targets for antiangiogenic therapy by comparing the gene expressions of tumor and normal endothelial cells
- (2014) Tsuguteru Otsubo et al. CANCER SCIENCE
- Suprabasin as a novel tumor endothelial cell marker
- (2014) Mohammad T. Alam et al. CANCER SCIENCE
- Advances in an active and passive targeting to tumor and adipose tissues
- (2014) Yu Sakurai et al. Expert Opinion on Drug Delivery
- Improvement of Doxorubicin Efficacy Using Liposomal Anti-Polo-like Kinase 1 siRNA in Human Renal Cell Carcinomas
- (2014) Yu Sakurai et al. MOLECULAR PHARMACEUTICS
- Biglycan up-regulated vascular endothelial growth factor (VEGF) expression and promoted angiogenesis in colon cancer
- (2014) Xiaojing Xing et al. TUMOR BIOLOGY
- Expression and significance of biglycan in endometrial cancer
- (2013) Yang Liu et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- The effect of liposomal size on the targeted delivery of doxorubicin to Integrin αvβ3-expressing tumor endothelial cells
- (2013) Golam Kibria et al. BIOMATERIALS
- Lysyl oxidase secreted by tumour endothelial cells promotes angiogenesis and metastasis
- (2013) T Osawa et al. BRITISH JOURNAL OF CANCER
- RNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA system
- (2013) Yu Sakurai et al. JOURNAL OF CONTROLLED RELEASE
- Gene Silencing via RNAi and siRNA Quantification in Tumor Tissue Using MEND, a Liposomal siRNA Delivery System
- (2013) Yu Sakurai et al. MOLECULAR THERAPY
- The F-prostaglandin receptor is a novel marker for tumor endothelial cells in renal cell carcinoma
- (2013) Kosuke Akiyama et al. PATHOLOGY INTERNATIONAL
- Inhibitory Role of the Small Leucine-Rich Proteoglycan Biglycan in Bladder Cancer
- (2013) Christian Niedworok et al. PLoS One
- Heterogeneity of Tumor Endothelial Cells
- (2012) Noritaka Ohga et al. AMERICAN JOURNAL OF PATHOLOGY
- Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells
- (2012) K Yamamoto et al. BRITISH JOURNAL OF CANCER
- Prostacyclin receptor in tumor endothelial cells promotes angiogenesis in an autocrine manner
- (2012) Takahiro Osawa et al. CANCER SCIENCE
- A pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivo
- (2012) Yusuke Sato et al. JOURNAL OF CONTROLLED RELEASE
- Biglycan
- (2012) Madalina V. Nastase et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- CXCR7: A novel tumor endothelial marker in renal cell carcinoma
- (2012) Nako Maishi et al. PATHOLOGY INTERNATIONAL
- Up-regulated biglycan expression correlates with the malignancy in human colorectal cancers
- (2011) Xiaohu Gu et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Biglycan expression correlates with aggressiveness and poor prognosis of gastric cancer
- (2011) Bin Wang et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Progress Toward In Vivo Use of siRNAs-II
- (2011) Garrett R Rettig et al. MOLECULAR THERAPY
- A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: A strategy for overcoming the PEG dilemma
- (2010) Hiroto Hatakeyama et al. ADVANCED DRUG DELIVERY REVIEWS
- Isolated tumor endothelial cells maintain specific character during long-term culture
- (2010) Kohei Matsuda et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Complementary Actions of Inhibitors of Angiopoietin-2 and VEGF on Tumor Angiogenesis and Growth
- (2010) H. Hashizume et al. CANCER RESEARCH
- Cytogenetic Abnormalities of Tumor-Associated Endothelial Cells in Human Malignant Tumors
- (2009) Tomoshige Akino et al. AMERICAN JOURNAL OF PATHOLOGY
- Adverse effects of anticancer agents that target the VEGF pathway
- (2009) Helen X. Chen et al. Nature Reviews Clinical Oncology
- Knocking down barriers: advances in siRNA delivery
- (2009) Kathryn A. Whitehead et al. NATURE REVIEWS DRUG DISCOVERY
- Microvascular endothelial cell heterogeneity: general concepts and pharmacological consequences for anti-angiogenic therapy of cancer
- (2008) Elise Langenkamp et al. CELL AND TISSUE RESEARCH
- Multifunctional envelope-type nano device (MEND) as a non-viral gene delivery system
- (2007) Kentaro Kogure et al. ADVANCED DRUG DELIVERY REVIEWS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now